An Inhaled Neutrophil Elastase Inhibitor Alleviates Lipopolysaccharide-Mediated Neutrophil Extracellular Trap Formation in Acute Lung Injury via the MAPK/AKT/NLRP3 Pathway
Research Square (Research Square)